Tadalafil
Product Images NDC 45865-991

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Tadalafil (NDC 45865-991). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medsource Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (991)

This is a medication label for Tadalafil, a generic version of a drug marked as "C", likely Cialis. The label suggests taking 20mg tablets once daily or as directed by a healthcare professional. It is unclear what "Y CAUSE HEX" and "9130 oazness" mean, as they may be misreadings from .*

FDA Label Image

Figure 5 (F005)

This text is describing the change from baseline in IPSS total score. It includes a comparison between Tadalafil Tablets 5 mg and Placebo, indicating a significant difference between the two (p<0.01). However, no further information is provided about the study or patient population. It also includes a duration of treatment of 4 to 12 weeks.*

FDA Label Image

Figure 6 (F006)

This is a report on IPSS total score, a medical assessment used to evaluate the severity of urinary symptoms. The report contains data on the efficacy of Tadalafil tablets (5mg) compared to a placebo in weeks of treatment. The text seems incomplete and contains random characters, indicating a possible error.*

FDA Label Image

Figure 7 (F007)

FDA Label Image

Figure 8 (F008)

This text appears to be a chart or graph, displaying the IPSS Total Score and the duration of treatment in weeks, with two groups represented by Tadalafil Tablets and Placebo. The asterisk and "p<0.01" suggest that there was a statistically significant difference between the two groups. However, the other characters such as "H", "F", "-", "a", "£", "2!", "°", and "S" do not provide any useful information and may be errors from the process.*

FDA Label Image

Figure1 (Figure1)

FDA Label Image

Figure2 (Figure2)

Not available.*

FDA Label Image

Figure3 (Figure3)

This appears to be a table or graph showing the systolic blood pressure in mmHg at different times after administration of either 20 mg tadalafil and 8 mg qd doxazosin, or placebo and 8 mg qd doxazosin. However, without the actual table or graph, it is difficult to provide more information.*

FDA Label Image

Figure4 (Figure4)

This text is a chart showing the plasma tadalafil concentrations in micrograms per liter (ug/L) at different time intervals (12, 24, 36, 48, 60, 72, 84, 96, 108, 120 hours) following the administration of different doses of tadalafil (20mg and 5mg) in single and once-daily doses for five consecutive days. The chart also includes symbols depicting the different doses. The text is useful to understand the plasma concentrations of tadalafil for different dosages and administration methods over time.*

FDA Label Image

Chemical Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.